18 EDITOR'S NOTE
Medication Reconciliation:
It's Time
FRED M. ECKEL, RPH, MS, SCD (HON)
CONTINUING Education
99 Current and Emerging
Therapeutics in Cystic Fibrosis:
Ensuring Continuity of Care
within the New Treatment
Paradigm
After completing this continuing
education program, participants
will be aware of changes regard-
ing the microbiology and patient
demographics of cystic fibrosis, to
optimize treatment efficacy and
adherence.
ROBERT J. KUHN, BS, PHARMD; ELIZABETH
AUTRY, PHARMD
110 Understanding and
Managing Rosacea in Your
Pharmacy
After completing this continuing
education program, participants
will be able to explain the patho-
physiology of rosacea, recognize its
signs and symptoms, differentiate
between the treatment options, and
identify counseling opportunities
for patients.
PEGGY PIASCIK, PHD, BSPHARM
MARKETPLACE Resources
120 Product Hotline
120 Advertisers' Index
CONTENTS DECEMBER • Heart Health
®
Vol. 81, No. 12
®
V l N 1 2
®
F
or the latest updates in research
on a range of health conditions,
visit our condition centers on
PharmacyTimes.com! Here is a sam-
pling:
■ ACUTE CORONARY
SYNDROME
Pharmacists can help
reduce hospitaliza-
tions among patients
with acute coronary
syndrome (ACS) by
understanding the
cause of medication nonadher-
ence. Learn about the risk factors in
"ACS Patient Nonadherence Factors
Pharmacists Should Target" on
PharmacyTimes.com.
■ COPD
Treating chronic pulmonary obstruc-
tive disease (COPD) with inhaled
corticosteroids and long-acting
bronchodilators remains contro-
versial, but this controller combi-
nation may reduce mortality risk.
Learn more in "COPD Controller
Combo May Lower Death Risk" on
PharmacyTimes.com.
■ HEART FAILURE
How patients experience heart fail-
ure is often worlds apart from the
way health care providers under-
stand it. Learn how to keep your
patients with heart failure healthy
by reading "To Understand Heart
Failure, Walk a Mile in the Patient's
Shoes" on PharmacyTimes.com.
■ PHARMACY WEEK IN
REVIEW
WEB WATCH
Watch highlights of the latest
pharmacy news at PharmacyTimes
.com/week-in-review.
n
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Pharmacy & Healthcare
Communications, LLC, the editorial staff, or any member of the editorial advisory board. Pharmacy & Healthcare Communications, LLC,
is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a war-
ranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Pharmacy & Healthcare
Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the
articles or advertisements.
See " CVS Strikes Deal for Repatha
Only; 18,000 Enroll in Long-term
Praluent CV Outcomes Trial" at
ajmc.com/newsroom .
ONLINE
RESOURCE:
AJMC.COM
December 2015 PharmacyTimes.com 15
68